Emergent Biosolutions Inc. (EBS) — 10-Q Filings

10-Q Filings (6)

• Emergent BioSolutions Swings to Profit Amid Revenue Dip — Oct 30, 2025 Risk: medium
  Emergent BioSolutions Inc. (EBS) reported a significant turnaround in its financial performance for the nine months ended September 30, 2025, achieving a net in
• Emergent BioSolutions Narrows Q2 Loss Amid Revenue Dip — Aug 7, 2025 Risk: medium
  Emergent BioSolutions Inc. reported a net loss of $10.5 million for the three months ended June 30, 2025, a significant improvement from the net loss of $30.2 m
• Emergent BioSolutions Files Q1 2025 10-Q — May 8, 2025 Risk: medium
  Emergent BioSolutions Inc. filed its quarterly report for the period ending March 31, 2025. The company's financial statements and disclosures for the first qua
• Emergent BioSolutions Files Q3 2024 10-Q — Nov 7, 2024 Risk: low
  Emergent BioSolutions Inc. filed its 10-Q for the quarterly period ended September 30, 2024. The company is incorporated in Delaware and headquartered in Gaithe
• Emergent BioSolutions Q2 2024 10-Q Filed — Aug 7, 2024 Risk: medium
  Emergent BioSolutions Inc. filed its 10-Q for the period ending June 30, 2024, reporting on its financial performance. The company's fiscal year ends on Decembe
• 10-Q Filing — May 2, 2024

Popular Companies

AAPL · TSLA · MSFT · AMZN · GOOGL · META · NVDA · JPM · BRK-B · V · JNJ · UNH · XOM · WMT · MA · PG · HD · DIS · BAC · NFLX